Hi there,

Independent media is more important than ever. Speaking up and telling the truth is becoming increasingly dangerous. Because we are only sponsored by you—not by governments or corporations—we can continue to bring you courageous journalism in a landscape filled with disinformation. If every person who came here for news this month gave just $15, we would be fully funded for a year. Thanks to a group of generous donors, all donations today will be TRIPLED, which means your $15 gift is worth $45. If you believe that freedom of speech and freedom of the press are essential to the functioning of a democratic society, please donate today. Every dollar makes a difference. Thank you so much.

Democracy Now!
Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Patients’ Advocates Seek Life-Saving Generic Hepatitis C Drugs

HeadlineFeb 16, 2017

In medical news, patients’ advocates have launched legal challenges to patents on hepatitis C drugs in India and Argentina, saying pharmaceutical companies are profiting from monopoly prices that leave millions unable to afford life-saving medications. In a statement, Médecins Sans Frontières, or Doctors Without Borders, said, “There are 80 million people worldwide living with hepatitis C, and we need a wide range of combination treatments available at an affordable price. With patents blocking generic competition, treatment remains prohibitively expensive in many countries.”

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top